A tribal confederation in Oregon has launched a mobile medication unit to deliver addiction treatment directly to tribal members. The initiative, part of the Great Circle Recovery program, aims to address the opioid crisis disproportionately affecting American Indians and Alaska Natives.
Researchers discovered that a little-understood synapse in the brain plays a pivotal role in producing myelin, the protective sheath around nerve cells. This finding could lead to new therapies for multiple sclerosis, neurodegenerative conditions and brain cancer.
A new study by Oregon Health & Science University researchers found that about half of the US's 160 residential addiction treatment centers have wait times over a month. The average daily cost for those who get in is $878, with facilities often requiring upfront payment.
A new study led by Oregon Health & Science University found that integrating physical and behavioral health services in Medicaid managed care did not lead to improved access or outcomes for patients. Despite the expectation that such integration would drive positive changes, the research revealed no statistically significant improvemen...
A study published in Molecular Cell describes how bacteria build a form of ubiquitin that helps cells communicate. The research sheds light on how different enzymes impact this protein during infection, providing an important first step towards understanding its role in diseases like Parkinson's and breast cancer.
Researchers discovered that individuals with obesity expel more energy at night compared to those with a healthy weight. During the day, people with obesity have higher insulin levels, indicating their body is working harder to process glucose.
A nationwide study found that nearly half of people who use illicit drugs in rural areas have been recently incarcerated. The study suggests that expanding addiction treatment to individuals while they're incarcerated could benefit communities overall by reducing overdose rates and improving rehabilitation outcomes.
Researchers at Oregon Health & Science University found that a low-fat diet significantly improved fatigue levels in patients with MS. The study, published in the Multiple Sclerosis Journal, suggests that diet alone can improve concentration and quality of life for patients with MS.
A patient at OHSU received a single stimulator implanted in the brain to effectively control two life-altering conditions: seizures caused by epilepsy and compulsive behavior caused by obsessive-compulsive disorder. The treatment, known as responsive neurostimulation system (RNS), has dramatically improved Pearson's quality of life.
A study published in Psychological Medicine found that the widely prescribed sedative alprazolam XR may be less effective than believed, with publication bias inflating its efficacy by over 40%. This suggests caution for patients and clinicians starting a prescription for panic disorder.
A study found that people with a specific genetic mutation in the CARD9 gene have higher IL-17 protein levels, making them more responsive to IL-17 inhibitor biologics. This discovery may lead to targeted treatment recommendations for ankylosing spondylitis patients.
Scientists at OHSU elucidated the structure of Type A GABA receptors targeted by antidepressants and other pharmaceutical drugs, shedding light on their role in brain function and development. The study reveals dominant assemblies and states of the receptor, paving the way for the development of new compounds with improved efficacy.
A new evaluation tool, HiDE, offers practical guidance for diagnosing hikikomori, a form of extreme social isolation. The tool provides structured interview questions for clinicians to diagnose the condition, which is characterized by stress caused by months-long isolation at home.
Researchers found that mature sperm carry only 100 organelles with mitochondria but no intact mtDNA. This discovery has important implications for human fertility and germ cell therapy, potentially limiting the risk of accumulating harmful mtDNA mutations.
Researchers found that ferroptosis, a form of cell death caused by iron buildup, destroys microglia cells in the brain's immune response, contributing to cognitive decline. The study's findings may lead to the development of compounds targeting microglial degeneration, offering new hope for Alzheimer's and vascular dementia treatments.
Researchers at Oregon Health & Science University have found that implanting a specific molecule in the brain can effectively reduce alcohol use among chronic heavy drinkers. The study showed a 90% reduction in drinking behavior in nonhuman primates, with the implanted virus permanently increasing dopamine levels and reducing cravings.
Researchers at OHSU identified a type of monoclonal antibody that can slow the progression of amyotrophic lateral sclerosis (ALS) by modulating immune cells. The study used a mouse model and confirmed results in human brains affected by ALS, revealing a promising potential treatment for this fatal neurodegenerative disease.
Research suggests that consuming THC during pregnancy can alter the placental and fetal epigenome, leading to changes in gene regulation and expression associated with neurobehavioral disorders. The study's findings highlight the need for better understanding of the potential long-term health impacts of prenatal cannabis exposure.
A vaccine originally developed to prevent bacteria-caused diarrhea has been found to also help infant nonhuman primates grow faster, according to a new study. The researchers found that vaccinated baby monkeys were taller than the unvaccinated when measured from head to toe, with a significant improvement in growth rate.
A new study finds nearly two-thirds of Medicare Advantage psychiatrist networks contain less than 25% of all psychiatrists, leaving many seniors without access to mental health care. The research suggests that this limited coverage may lead to higher out-of-pocket costs, delays in care, and foregone treatment.
A recent study found wide discrepancies in treatment for opioid use disorder among people covered by Medicaid, with some states providing nearly universal access to proven medications. The study suggests that quality of care problems are to blame for the disparities.
A new study reveals that only one in four adolescent residential treatment centers across the US provides buprenorphine, a proven tool in fighting opioid addiction. The lack of access to this medication undercuts US efforts to alleviate the overdose epidemic, which claimed over 109,000 lives in 2022.
Researchers from Oregon Health & Science University have discovered how stem cell transplantation can kill the virus that causes AIDS. The study, published in the journal Immunity, reveals that two circumstances must co-exist for a cure to occur and documents the order in which HIV is cleared from the body.
Physicians are urging primary care teams to use data-driven approaches to prevent and mitigate climate-related health issues, dubbed "precision ecologic medicine". This approach combines patient-specific data with climate-related information to predict and support vulnerable patients.
Researchers assembled the largest atlas of post-zygotic genome mutations in healthy human tissue, providing insight into genetic underpinnings of disease. The study found that most detectable mutations occurred later in life, but some arose systematically and predictably as people age.
A global study of 9,555 individuals found a 4% increase in heavy bleeding days and total bleeding quantity after COVID-19 vaccination. Changes often resolve by the first post-vaccination menstrual cycle.
A new study by Oregon Health & Science University reveals a significant variance in Medicaid reimbursement rates for mental health services across US states. The study found that Nebraska, Alaska, and Arkansas reimburse at the highest rates, while Pennsylvania, Rhode Island, and Maine reimburse the least for the same set of services.
Researchers have found lab-made antibodies that can strengthen the body's fight against yellow fever, a disease with no current treatment. The monoclonal antibody infusions were able to remove all signs of infection from research animals, offering potential hope for a cure.
A new study has confirmed that chronic THC use can negatively impact male reproductive health, including testicular function and sperm quality. Discontinuing use of THC for at least four months can partially restore these effects, providing a critical window for family planning and conception.
A new study led by OHSU researchers reveals that gene editing technology in human embryos can lead to unintended changes in the genome and may not accurately reflect gene edits. The study highlights the need for caution when using genetically edited embryos to establish pregnancies.
Researchers identified apremilast as an incredibly promising treatment for alcohol use disorder, reducing consumption by more than half in a clinical trial. The medication, approved for psoriasis and psoriatic arthritis, triggers increased activity in the brain's nucleus accumbens to control alcohol intake.
A new nonhuman primate model of Usher syndrome has been confirmed, providing hope for the development of a treatment for this leading cause of blindness-deafness. The model, created using CRISPR/Cas9 technology, exhibits symptoms similar to those experienced by humans with the condition.
Researchers found that some states, such as Ohio and Nevada, have the highest per-capita visits to emergency departments for mental health conditions, while others, like Colorado and West Virginia, have the lowest. Heavy reliance on emergency departments is problematic due to a lack of suitable care in these areas.
A study by OHSU researchers found that immunity from COVID-19 gathers strength over time, indicating that vaccination should not be delayed. The study suggests that vaccine boosters can be spaced no more frequently than a year apart among healthy individuals.
A new approach to gene therapy for inherited blindness uses lipid nanoparticles to deliver mRNA inside the eye, targeting light-sensitive cells and creating proteins that edit vision-harming gene mutations. The technology has shown promising results in animal studies, including mice and nonhuman primates.
Research reveals private equity firms experience greater replacement of the workforce and rely on physician assistants and nurse practitioners. A more stable workforce is associated with better health outcomes for patients.
A new publication highlights the challenges patients face in accessing effective opioid treatment. Opioid addiction specialists from Oregon Health & Science University argue for a flexible, responsive health system that prioritizes patient needs.
Researchers developed a nanoparticle-based approach that uses photoacoustic imaging and infrared light to detect and potentially treat ectopic pregnancies. The technology shows promise in mice studies and may offer a non-invasive and effective way to improve diagnosis and treatment of the condition.
A nationwide study found that hundreds of residents in neurological surgery trained on a first-of-its-kind simulator, mirroring real-life catastrophe scenarios. The simulation model was deemed feasible and cost-effective, similar to pre-flight simulators used by pilots.
Researchers at OHSU discovered adenosine effectively acts as a brake to dopamine, promoting balance in neuronal signaling. This finding suggests new avenues for drug development to treat Parkinson's disease symptoms by targeting the push-pull dynamic between dopamine and adenosine.
Researchers at Oregon Health & Science University have counted more than 10,000 nerve fibers in the human clitoris, exceeding previous estimates of 8,000. This discovery could lead to better outcomes for phalloplasty surgery and improved sensation for transmasculine patients.
Scientists at OHSU have identified synaptotagmin-3 (SYT3) as a crucial protein for replenishing neurotransmitters between neurons. This discovery sheds new light on the underlying causes of neurological disorders such as epilepsy and autism, and may lead to the development of gene therapies or pharmaceutical approaches targeting SYT3.
Researchers at OHSU have revealed the structure of the key part of the inner ear responsible for hearing, a long-standing mystery. The discovery could lead to new treatments for hearing impairments affecting over 460 million people worldwide.
A new study from OHSU reveals that breakthrough infections following vaccination can provide a potent immune response against COVID-19, with increased protection for those 65 and older. The research found an equally strong immune response among people who received a third vaccine booster dose three months prior.
A recent study found that private equity firms acquiring physician-owned medical practices increase patient volume and billing for visits, raising concerns about the corporatization of healthcare. The study examined 578 physician practices acquired by private equity firms between 2016 and 2020.
A new study reveals that methamphetamine use is widespread in rural America, driving overdoses and deaths. The research found that people using both methamphetamine and opioids had a significantly higher risk of nonfatal overdose, with 22% reporting an overdose in the past six months.
A study published in Annals of Internal Medicine found that telehealth can improve clinical outcomes and patient satisfaction for pregnant mothers and their infants. The researchers analyzed 28 randomized controlled trials and 14 observational studies to assess the effect of telehealth-delivered care on maternal health outcomes.
Researchers at OHSU developed an efficient and accurate assessment of placental health using standard MRI, detecting complications early in pregnancy. The method identifies T2* values that provide key information about oxygen availability and placental blood flow.
A recent study found that 49% of transgender and gender-diverse patients who undergo gender-affirming genital surgery travel outside their home state, resulting in significantly higher out-of-pocket medical expenses. The average out-of-state patient pays $2,645, compared to $1,781 for in-state patients.
Researchers aim to develop a gene therapy that could suppress HIV replication and eliminate the need for life-long antiretroviral therapy. The study uses an AAV vector to produce leronlimab, a monoclonal antibody blocking HIV entry into immune cells.